tiprankstipranks
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market
SYRE
Spyre Therapeutics
RESEARCH TOOLSreports

Spyre Therapeutics (SYRE) Revenue

517 Followers
StatisticsMarket CapRevenue

Spyre Therapeutics Revenue

Spyre Therapeutics had a revenue of 90.49M in the quarter ending Dec 31, 2025, with Infinity%. This bring the company's revenue in the last twelve months to 90.49M, Decreased Infinity%. In the fiscal year ending Dec 31, 2025, Spyre Therapeutics had annual revenue of 0.00 with ― growth.
Revenue (ttm)
90.49M
Revenue Growth
―
P/S Ratio
―
Revenue/Employee
$0
Employees
73
Market Cap
$4.08B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
―――
Dec 31, 2024
―-886.00K-100.00%
Dec 31, 2023
886.00K-1.44M-61.96%
Dec 31, 2022
2.33M-16.41M-87.57%
Dec 31, 2021
18.74M―+∞%
Dec 31, 2020
―――
Dec 31, 2019
―-3.89M-100.00%
Dec 31, 2018
3.89M-1.32M-25.30%
Dec 31, 2017
5.21M――